SeaSpine

Systems

BodyForm Thoraco Fixation Instructions for Use

3 Pages

QF-10-01-74-ENGL-D  BodyForm™ - English Thoraco-Lumbar and Thoracic Fixation System Rx Only Caution: Federal Law restricts this device to sale by or on the order of physician Manufacturer: SeaSpine Orthopedics Corporation 5770 Armada Drive Carlsbad, CA 92008, USA Telephone: 760-727-8399 Fax: 760-727-8809 Complaints: complaints@seaspine.com Customer Service: customerservice@seaspine.com Website: www.seaspine.com  DESCRIPTION The BodyForm Thoraco-Lumbar and BodyForm Thoracic Fixation Systems consist of a variety of shapes and sizes of plates, screw lengths, set screws and instrumentation.      INDICATIONS FOR USE BodyForm Thoraco-Lumbar Fixation System The SeaSpine BodyForm Thoraco-Lumbar Fixation System is indicated for treatment of anterior thoracolumbar spinal instability caused by:       Trauma Tumor Degenerative Disc Disease (DDD). Defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. Anterior fusion following multiple failed posterior fusion operations, including pseudarthrosis.  The instrumentation is designed for levels of fixation from T10 to L4. The plates are intended for attachment to the left-side lateral elements of the vertebral bodies. The anatomically-specific design of the plates will not fit the right-side anatomy. In no case should the plates be attached directly to the anterior aspect of the vertebral body. BodyForm Thoracic Fixation System The SeaSpine BodyForm Thoracic Fixation System is intended as an adjunct to fusion for treatment of thoracic spinal instability as a result of:           Trauma Tumor Spondylolisthesis Spinal stenosis Degenerative Disc Disease (DDD). Defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies: Deformities or curvature (scoliosis, kyphosis, and/or lordosis) Anterior fusion following failed previous fusion operations, including pseudarthrosis.  The BodyForm Thoracic Fixation System is intended for unilateral use to attach to the anterolateral aspect of the vertebral bodies at levels of fixation from T1 to L1. IMPLANT MATERIALS Titanium alloy, Ti-6Al-4V (ELI) per ASTM F136 CONTRAINDICATIONS Any medical or surgical condition which would preclude the potential benefit of spinal implant surgery is a contraindication. The following conditions may reduce the chance of a successful outcome and should be taken into consideration by the surgeon. This list is not exhaustive:  Absolute contraindications:  Infection in or around the operative site  Allergy or sensitivity to implant materials  Any case not described in the indication Relative contraindications:  Local inflammation  Morbid obesity  Pregnancy  Fever or leukocytosis  Prior fusion at the level(s) to be treated  Grossly distorted anatomy due to congenital abnormalities  Rapid joint disease, bone absorption, osteopenia, and/or osteoporosis  Elevation of sedimentation rate unexplained by other diseases, elevation of white blood count (WBC), or a marked left shift in the WBC differential count  Any case not requiring bone graft and fusion or where fracture healing is not required  Patients having inadequate tissue coverage over the operative site or where there is inadequate bone stock, bone quality, or anatomical definition  Unsuitable or insufficient bone support  Bone immaturity  The patient’s activity level, mental condition, occupation and/or a patient unwilling to cooperate with the postoperative instructions  Any case where implant utilization would interfere with anatomical structures or expected physiological performance  Use of incompatible components and/or materials from other systems  POSSIBLE ADVERSE EVENTS Like other spinal system implants, the following adverse events are possible. This list is not exhaustive:  Delayed union or nonunion (pseudarthrosis)  Bending, disassembly or fracture of implant and components  Loosening of spinal fixation implants may occur due to inadequate initial fixation, latent infection, and/or premature loading, possibly resulting in bone erosion, migration or pain  Pain, discomfort, or abnormal sensations due to the presence of the device  Pressure on skin where inadequate tissue coverage exists over the implant, with potential extrusion through the skin.  Dural leak requiring surgical repair.  Cessation of growth of the fused portion of the spine.  Subsidence of the implant into adjacent bone.  Loss of proper spinal curvature, correction, height and/or reduction.  Increased biomechanical stress on adjacent levels.  Improper surgical placement of the implant causing stress shielding of the graft or fusion mass.        Single Use Only  Catalog Number  Lot Number (Batch Code)  Non-Sterile  Manufacturer  Material  Caution, Consult Accompanying Documents  Consult Instructions for Use www.seaspine.com/eIFU  Medical Device  Date of Manufacture  Intraoperative fissure, fracture, or perforation of the spine. Postoperative fracture due to trauma, defects, or poor bone stock. Serious complications associated with any surgery may occur. These include, but are not limited to: wound complications, infection, genitourinary disorders, gastrointestinal disorders, vascular disorders, including thrombus; bronchopulmonary disorders, including emboli; bursitis, hemorrhage, myocardial infarction, paralysis or death.  WARNINGS AND PRECAUTIONS Patients with previous spinal surgery at the level(s) to be treated may have different clinical outcomes compared to those without previous surgery. The safety and effectiveness of spinal systems have been established only for spinal conditions with significant mechanical instability or deformity requiring fusion with instrumentation. These conditions are significant mechanical instability or deformity of the spine secondary to severe spondylolisthesis, degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor and failed previous fusion (pseudarthrosis). The safety and effectiveness of these devices for any other condition is unknown.  The implantation of this system should be performed only by experienced spinal surgeons with specific training in the use of this device because this is a technically demanding procedure presenting a risk of serious injury to the patient.  Based on the fatigue testing results, the surgeon should consider the levels of implantation, patient weight, patient activity level, other patient conditions, etc. which may impact the performance of the system  Ensure all implants, components or instruments are sterilized prior surgery. The use of non-sterile devices may lead to inflammation, infection or disease.  Implants should never be reused under any circumstances. A used implant should be discarded. While the implant may appear undamaged, it may have small defects or internal stress patterns and if implanted, could fail to perform as intended and pose safety risks to the patient. The risks include, but are not limited to, mechanical failure, breakage, difficulty with implantation, incompatibility with mating components and infection.  This device is not intended for screw attachment or fixation to the posterior elements (pedicles) of the cervical, thoracic, or lumbar spine.  Do not use components from other systems that are composed of incompatible materials such as stainless steel.   Page 1 of 3
File Type: PDF
File Size: 134 KB
File Name: SeaSpine - QF-10-01-74-ENGL-D - BodyForm Thoraco Fixation Instructions for Use - Rev D.pdf

By clicking Download you are confirming this is the correct document for your purposes
and that you agree to our Terms & Conditions